NASDAQ:JWEL Jowell Global 4/30/2026 Earnings Report $2.48 -0.07 (-2.75%) As of 03:55 PM Eastern This is a fair market value price provided by Massive. Learn more. ProfileEarnings History Jowell Global EPS ResultsActual EPS-$1.15Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/AJowell Global Revenue ResultsActual Revenue$44.42 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/AJowell Global Announcement DetailsQuarterDate4/30/2026TimeAfter Market ClosesConference Call DateN/AConference Call TimeN/AConference Call ResourcesEarnings HistoryCompany Profile Jowell Global Earnings HeadlinesJowell Global Alters Financing Strategy with New Promissory NoteNovember 18, 2025 | msn.comJowell Global Secures $2.8 Million Through Private Share PlacementOctober 20, 2025 | tipranks.comALERT: Drop these 5 stocks before the market opens tomorrow!The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings research points to the first half of 2026 as a particularly rough stretch for certain holdings. Some of America's most popular stocks could take serious damage as a radical market shift plays out. Analysts at Weiss Ratings have identified five names you may want to remove from your portfolio before this unfolds. If any of these are in your portfolio, now is the time to review your positions.May 5 at 1:00 AM | Weiss Ratings (Ad)Jowell Global files $118.9M mixed securities shelfAugust 26, 2025 | msn.comExpensify Inc. (EXFY) vs. Jowell Global Ltd. (JWEL): Which Small-Cap Stock Offers More Upside?December 21, 2024 | stocknews.comJowell Global Reports Revenue Growth Amid Cost-Cutting EffortsDecember 20, 2024 | markets.businessinsider.comSee More Jowell Global Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Jowell Global? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Jowell Global and other key companies, straight to your email. Email Address About Jowell GlobalJowell Global (NASDAQ:JWEL) Limited is a Cayman Islands exempted special purpose acquisition company (“SPAC”) formed to effect a merger, capital stock exchange, asset acquisition or similar business combination with one or more private businesses. The company has no commercial operations of its own and holds its funds in trust pending the completion of an initial business combination. Since its formation, Jowell Global has targeted opportunities in the technology, consumer and healthcare sectors, with a particular focus on companies operating in Greater China and North America. The SPAC structure allows it to leverage public market financing to pursue cross-border growth opportunities and to partner with established management teams in high-growth industries. Jowell Global’s sponsor and leadership team draw on experience in investment banking, private equity and corporate advisory services to identify and evaluate potential acquisition targets. The board and executive officers work together to conduct due diligence, negotiate transaction terms and prepare prospective business combinations for shareholder approval.View Jowell Global ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles Palantir Drops After a Blowout Q1—What Investors Should KnowShopify’s Valuation Crisis Creates Opportunity in 2026onsemi Stock Dips After Earnings: Why the Dip Is BuyableTSLA: 3 Reasons the Stock Could Hit $400 in MayNebius Breaks Out to All-Time Highs—Here's What's Driving It.3 Reasons Analysts Love DexComMonolithic Power Systems: AI Stock Beat, Raised and Upgraded Post-Earnings Upcoming Earnings ARM (5/6/2026)AppLovin (5/6/2026)DoorDash (5/6/2026)Fortinet (5/6/2026)Marriott International (5/6/2026)Warner Bros. Discovery (5/6/2026)Apollo Global Management (5/6/2026)Cencora (5/6/2026)Cenovus Energy (5/6/2026)CVS Health (5/6/2026) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
